Healthcare
HUM Stock Analysis
Humana Inc. · current price $385.64 (-1.75% today)
Solid setup — 26% revenue growth, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
★★★★
Quality
HUM Stock AnalysisHumana Inc. · current price $385.64 (-1.75% today)
Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.
Reading HUM’s price and volume history…
Checking the areas that decide this thesis…
AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.
Reading HUM’s filings…
| Quarter | EPS | Est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-30 | $3.24 | $2.83 | +14.6% | Beat |
| 2025-12-31 | $-3.96 | $-3.99 | +0.7% | Beat |
| 2026-03-31 | $10.31 | $10.20 | +1.1% | Beat |
| 2026-06-30 | $7.61 | $7.00 | +8.8% | Beat |
Humana Inc. (HUM) currently has a TickerMover Quant Score of 67/100, rated ★★★★ Quality. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.
TickerMover does not give buy or sell recommendations. HUM scores 67/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.
HUM's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.
Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.
Open the dashboard for HUM →
